Vaxart, Inc.
VXRTNASDAQHealthcare● Active
$0.60
$-0.02(-3.44%)
Market Cap$144912237
P/E Ratio—
52W High$0.84
52W Low$0.26
Vaxart, Inc. (VXRT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · VXRT · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.24B | $0.03B | $0.01B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.05B |
| Gross Profit | $0.24B | $0.03B | $0.00B | $0.00B | ($0.05B) |
| Gross Margin %(computed) | 100.00% | 100.00% | 39.02% | 100.00% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.20B | $0.07B | $0.07B | $0.08B | $0.05B |
| G&A Expenses | $0.02B | $0.02B | $0.02B | $0.03B | $0.02B |
| Total Operating Expenses | $0.22B | $0.09B | $0.09B | $0.11B | $0.02B |
| Operating Income | $0.02B | ($0.07B) | ($0.08B) | ($0.11B) | ($0.07B) |
| Operating Margin %(computed) | 7.62% | -230.99% | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.02B | ($0.07B) | ($0.08B) | ($0.11B) | ($0.07B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.02B | ($0.07B) | ($0.08B) | ($0.11B) | ($0.07B) |
| Net Margin %(computed) | 6.88% | -233.27% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.07 | $-0.14 | $-0.17 | $-0.22 | $-0.14 |
| Wtd Avg Shares | 0.23B | 0.49B | 0.49B | 0.49B | 0.49B |
| EBITDA | $0.03B | ($0.05B) | ($0.07B) | ($0.10B) | ($0.07B) |
| EBITDA Margin %(computed) | 11.89% | -191.18% | -977.54% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Vaxart, Inc. data
About Vaxart, Inc. (VXRT) Income Statement
Vaxart, Inc. (VXRT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, VXRT reported revenue of $0.24B, gross profit of $0.24B (gross margin 100.00%), and net income of $0.02B — a net profit margin of 6.88%.
Frequently asked questions
VXRT · 4 questionsVaxart, Inc. (VXRT) reported revenue of $0.24B for 2025, up 726.7% year-over-year.
VXRT revenueVXRT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09